Vascular Biology Unit, School of Medicine and Dentistry, James Cook University, Townsville QLD 4811, Australia.
Eur Heart J. 2011 Feb;32(3):354-64. doi: 10.1093/eurheartj/ehq171. Epub 2010 Jun 8.
A number of biomarkers have been associated with abdominal aortic aneurysm (AAA), but there has been no assessment of how such markers along with clinical risk factors can be used to stratify the risk of AAA presence and its progression. The aims of this study were to assess the diagnostic, prognostic, and risk stratification potential of plasma D-dimer for AAA presence and growth.
We included 1260 subjects (337 with AAA) recruited from a population screening study and 132 (41 with AAA) from a referral clinic. A total of 299 of the population group were followed by repeat ultrasound imaging for a median of 5.5 years to monitor AAA growth. The diagnostic and prognostic potential of plasma D-dimer was assessed by multivariate regression (adjusting for other AAA risk factors), receiver operator characteristic, and classification and regression tree (CART) analyses. In both groups, the dominant risk factor for AAA was D-dimer; thus in the population group, cut-off values of > 400 and > 900 ng/mL had adjusted odds ratios of 12.1 (95% CI 7.1-20.5) and 24.7 (95% CI 13.7-44.6), respectively. In both groups, CART analyses confirmed the dominating role of plasma D-dimer in defining extreme risk-groups with AAA prevalence as disparate as 3 and 82%. Average yearly AAA growth was positively and significantly associated with D-dimer which was able to predict growth as disparate as 0.4 and 2.5 mm/year.
This study suggests that plasma D-dimer can play a role in the diagnosis and prognosis of AAA.
许多生物标志物与腹主动脉瘤(AAA)相关,但尚未评估这些标志物与临床危险因素结合如何用于分层 AAA 存在及其进展的风险。本研究旨在评估血浆 D-二聚体对 AAA 存在和生长的诊断、预后和风险分层潜力。
我们纳入了一项人群筛查研究中的 1260 名受试者(337 名患有 AAA)和一个转诊诊所中的 132 名受试者(41 名患有 AAA)。人群组中有 299 名受试者通过重复超声成像进行了中位数为 5.5 年的随访,以监测 AAA 生长。通过多元回归(调整其他 AAA 危险因素)、接收者操作特征和分类回归树(CART)分析评估了血浆 D-二聚体的诊断和预后潜力。在两组中,AAA 的主要危险因素都是 D-二聚体;因此,在人群组中,>400 和>900ng/mL 的 D-二聚体截断值的调整比值比分别为 12.1(95%CI 7.1-20.5)和 24.7(95%CI 13.7-44.6)。在两组中,CART 分析均证实了血浆 D-二聚体在定义 AAA 患病率差异悬殊(3%和 82%)的极高风险组中的主导作用。平均每年的 AAA 生长与 D-二聚体呈正相关,且具有显著意义,D-二聚体可预测差异悬殊(0.4 和 2.5mm/年)的生长。
本研究表明,血浆 D-二聚体在 AAA 的诊断和预后中可能发挥作用。